Optometrists in Princeton, MN Accepting Medicare

4 Optometrists found. Showing 1 - 4

Dr. Glenn Orville Kallevig, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 101 S Rum River Dr, Princeton, MN 55371 Phone: 763-389-9000

Edina Eye Physicians And Surgeons Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 919 Northland Dr, Princeton, MN 55371 Phone: 763-241-5878    Fax: 763-241-5877

Ronald Huebsch, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 523 1st St, Princeton, MN 55371 Phone: 763-389-3150    Fax: 763-389-0664

Daniel William Solbrack, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 523 1st St, Princeton, MN 55371 Phone: 763-389-3150

News Archive

KaloBios Pharmaceuticals, Sanofi Pasteur partner in development of KB001 biologic for Pa infections

KaloBios Pharmaceuticals, Inc. today announced an agreement with Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, for the development and commercialization of KB001, an investigational new biologic for the treatment or prevention of Pseudomonas aeruginosa (Pa) infections. Sanofi Pasteur will be responsible for the development and commercialization of KB001 and initially focus on hospital indications, including the prevention of Pa pneumonias in mechanically ventilated patients.

Study suggests that high-volume nursing facilities better for hip fracture patients

There isn't a lot of information available to help family caregivers choose the best skilled nursing facility for an elderly loved one who breaks a hip, but a new study suggests a potentially useful quality indicator: the facility's number of hip fracture patients during the prior year.

Albert Einstein College of Medicine and Montefiore establish Office of Clinical trials

Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University have established an Office of Clinical Trials (OCT) to bring new therapies more rapidly to patients through the facilitation of efficient, compliant and timely conduct and management of clinical studies.

Cymbalta significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression

The antidepressant Cymbalta (duloxetine HCl), a dual-reuptake inhibitor of serotonin and norepinephrine, 60 mg once or twice daily, significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression, according to 12-week data presented at the annual meeting of the American College of Rheumatology.

$40 million multi-year study to examine long-term impacts of COVID-19 and MIS-C

Up to 2,000 children and young adults will be enrolled in a study from Children's National Hospital in collaboration with the National Institute of Allergy and Infectious Diseases that will examine the long-term effects of COVID-19 and multisystem inflammatory syndrome in children (MIS-C) after these patients have recovered from a COVID-19 infection.

Read more Medical News

› Verified 6 days ago